Prokidney Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Prokidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
/ 
Frequently asked questions
To buy Prokidney Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Prokidney Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Prokidney Corp. is PROK:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Prokidney Corp. has its primary listing on NASDAQ. You can trade Prokidney Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Prokidney Corp. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Prokidney Corp. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Prokidney Corp..